HELINEXA™ common law trademark held by HELINEXA TECHNOLOGY LLC owns common law rights to the HELINEXA™ trademark. This site is operated by U&G Biotechnology (Hangzhou) Co., Ltd., authorized contract manufacturer of HELINEXA research reagents. Domain www.helinexahealth.com redirects here.

sales@ugbio.cn

86-400-8803657

86-571-85300625

Explore Life Sciences, Protect Human Health!

中文

U&G Biotechnology (Hangzhou) Co., Ltd.

Recently added:

    in total 0 items Total 0

    News and Information

    11

    2025-02

    U&G Biotechnology receives the National High-Tech Enterprise Certification!

    On December 26, 2024, the Office of the National Leading Group for the Management of High-Tech Enterprise Recognition released the "List of Registered High-Tech Enterprises Reported by Zhejiang Province's Designated Institutions in 2024." YooGene Biotech has officially been awarded the national High-Tech Enterprise certification! This is not only the highest recognition of our past efforts but also a promising outlook for the exciting journey ahead.

    11 Feb,2025

    11

    2025-02

    Cybersecurity for the People

    The Ministry of Public Security attaches great importance to cracking down on and addressing illegal activities related to "online water armies." Relying on the targeted "Clean Web 2024" campaign, it is launching a full-scale offensive, focusing on prominent criminal activities such as spreading rumors to drive traffic, manipulating public opinion for extortion, inflating metrics to control reviews, and offering paid services to delete online posts. Nationwide, public security authorities have been deployed to carry out comprehensive enforcement efforts.

    11 Feb,2025

    08

    2023-11

    Great news! U&G Biotechnology has successfully achieved ISO 9001 and ISO 13485 quality management system certifications.

    In October 2023, after a two-phase audit by review experts from Beijing Guoyi Xiehuaguang Certification Co., Ltd., U&G Biotechnology (Hangzhou) Co. Ltd successfully achieved ISO 9001:2015 and ISO 13485:2016 certifications and received the corresponding certificates. This milestone underscores that our company’s quality management system now meets international standards and regulatory requirements.

    08 Nov,2023

    22

    2021-10

    The National Health Commission has recently issued a document—Announcing the "14th Five-Year Plan for the Development of Clinical Specialty Capabilities."

    On October 18, to further strengthen clinical specialty capacity building and fully leverage its critical role in driving high-quality development of public hospitals, the National Health Commission organized the drafting and release of the "National Clinical Specialty Capacity Building Plan for the 14th Five-Year Period," providing guidance to regions across the country on how to effectively advance clinical specialty development during this period.

    22 Oct,2021

    The National Health Commission has recently issued a document—Announcing the "14th Five-Year Plan for the Development of Clinical Specialty Capabilities."
    < 1 >
    U&G Biotechnology (Hangzhou) Co., Ltd.

    HELINEXA TECHNOLOGY LLC

    2212A POT SPRING RD, LUTHERVILLE-TIMONIUM, MD 21093, USA Holder of common law rights to the HELINEXA™ mark and North American brand operator.

    U&G Biotech (Hangzhou) Co., Ltd.

    Building 2, 1st Floor, No. 265 Chengrui Street, Xiasha Subdistrict, Qiantang District, Hangzhou City, Zhejiang Province, China China Authorized Contract Manufacturer for HELINEXA™ branded research products.

    Friendly Links:

    ************** | ************** | **************

    ************** | ************** | **************

    te

    Phone: +86-571-85300625 / +86-400-880 3657

    email

    Technical Support: support@ugbio.cn

    email

    Sales Consultation: sales@ugbio.cn

    email

    Talent Recruitment: hr@ugbio.cn

    North America: info@helinexahealth.com

    Contract Manufacturing Inquiry (China): +86-400-880 3657 (Domestic China only)

    Domain www.helinexahealth.com is the official domain for HELINEXA™ life science research products and redirects to this website.

    COOKIES

    Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

    COOKIES

    Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

    These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

    These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

    These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

    These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

    U&G Biotechnology (Hangzhou) Co., Ltd.

    Business License

    Powered by 300.cn  |  Privacy Policy

    Internet Drug Information Service Qualification Certificate [-Non-operating-2021]

    1

    Leave a message

    If you're interested in our products and would like to learn more, please leave a message here. We'll get back to you as soon as possible.

    Submit